Regulatory 2024-08-15 | Half-Year Report 2024: Orviglance Completes Clinical Development with Successful Phase 3 Study PDF Report Presentation Webcast
Regulatory 2023-08-18 | Half-Year report 2023: Re-evaluation required after intra-reader inconsistency in scoring of images from phase 3 study SPARKLE PDF Report Presentation Webcast
Regulatory 2022-08-18 | Half-year report 2022: Strong results from Orviglance Food Effect Study PDF Report Presentation Webcast
Regulatory 2021-08-19 | Quarterly Report Q2 2021: Preparing Oncoral for the next level PDF Report Presentation Webcast
Regulatory 2020-08-20 | Quarterly Report Q2-2020: First participant in the hepatic study PDF Report Presentation Webcast
